AI (Artificial Intelligence) refers to creation of unique systems with the help of software which can perform certain tasks without human intervention and instructions. AI comprises integration of various technologies like machine learning, reasoning, perception, natural language processing. AI is primary used in healthcare sector for diagnosis and treatment.
Increase in applications of AI (artificial intelligence) in healthcare industry is the key driving factor which is expected to boost the global artificial intelligence in diagnostics market growth. Furthermore, rise in demand for reducing diagnostic costs, reducing machine downtime and improving patient care will accelerate the usage of artificial intelligence in diagnostics and which is expected to propel the market growth during this forecast period. Also, increase in collaboration and partnership activities among various AI solution providers and health facilities will positively contribute the market growth. Moreover, continuous advancements in artificial intelligence and deep learning are expected to prove more efficient in identifying disease diagnosis over the upcoming years.
However, lack of skilled AI workforce and ambiguous regulatory guidelines for diagnostic software is the major challenging factor which is expected to hinder the global artificial intelligence in diagnostics market growth during this analysis period.
Global Artificial Intelligence in Diagnostics Market is segmented into component such as Software, Hardware, and Services. Further, market is segmented into diagnosis type such as Cardiology, Oncology, Pathology, Radiology, Neurology, and Others.
Also, Global Artificial Intelligence in Diagnostics Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific,
Various key players are discussed in this report such as GE Healthcare,Siemens Healthcare GmbH, IDx Technologies Inc., Vuno Inc., Imagen Technologies, AliveCor, Aidoc, Neural Analytics, Riverain Technologies, and Zebra Medical Vision
By Component Software Hardware Services
By Diagnosis Type Cardiology Oncology Pathology Radiology Neurology Others
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Artificial Intelligence in Diagnostics Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5. Global Artificial Intelligence in Diagnostics Market, By Component
5.1 Y-o-Y Growth Comparison, By Component
5.2 Global Artificial Intelligence in Diagnostics Market Share Analysis, By Component
5.3 Global Artificial Intelligence in Diagnostics Market Size and Forecast, By Component
5.3.1 Software
5.3.2 Hardware
5.3.3. Services
6 .Global Artificial Intelligence in Diagnostics Market, By Diagnosis Type
6.1 Y-o-Y Growth Comparison, By Diagnosis Type
6.2 Global Artificial Intelligence in Diagnostics Market Share Analysis, By Diagnosis Type
6.3 Global Artificial Intelligence in Diagnostics Market Size and Forecast, By Diagnosis Type
6.3.1 Cardiology
6.3.2 Oncology
6.3.3 Pathology
6.3.4. Radiology
6.3.5. Neurology
6.3.6 .Others
7Global Artificial Intelligence in Diagnostics Market, By Region
7.1 Global Artificial Intelligence in Diagnostics Market Share Analysis, By Region
7.2 Global Artificial Intelligence in Diagnostics Market Share Analysis, By Region
7.3 Global Artificial Intelligence in Diagnostics Market Size and Forecast, By Region
8North America Artificial Intelligence in Diagnostics Market Analysis and Forecast (2020 – 2030)
1 Introduction
8.2 North America Artificial Intelligence in Diagnostics Market Share Analysis, By Component
8.3 North America Artificial Intelligence in Diagnostics Market Size and Forecast, By Diagnosis Type
8.4 North America Artificial Intelligence in Diagnostics Market Size and Forecast, By Country
8.4.1 U.S
8.4.2 Canada
8.4.3 Mexico
9Europe Artificial Intelligence in Diagnostics Market Analysis and Forecast (2020 – 2030)
9.1 Introduction
9.2 Europe Artificial Intelligence in Diagnostics Market Share Analysis, By Component
9.3 Europe Artificial Intelligence in Diagnostics Market Size and Forecast, By Diagnosis Type
9.4 Europe Artificial Intelligence in Diagnostics Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10Asia Pacific Artificial Intelligence in Diagnostics Market Analysis and Forecast (2020 – 2030)
10.1 Introduction
10.2 Asia Pacific Artificial Intelligence in Diagnostics Market Share Analysis, By Component
10.3 Asia Pacific Artificial Intelligence in Diagnostics Market Size and Forecast, By Diagnosis Type
10.4 Asia Pacific Artificial Intelligence in Diagnostics Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11Latin America Artificial Intelligence in Diagnostics Market Analysis and Forecast (2020 – 2030)
11.1 Introduction
11.2 Latin America Artificial Intelligence in Diagnostics Market Share Analysis, By Component
11.3 Latin America Artificial Intelligence in Diagnostics Market Size and Forecast, By Diagnosis Type
11.4 Latin America Artificial Intelligence in Diagnostics Market Size and Forecast, By Country
12Middle East Artificial Intelligence in Diagnostics Market Analysis and Forecast (2020 – 2030)
12.1 Introduction
12.2 Middle East Artificial Intelligence in Diagnostics Market Share Analysis, By Component
12.3 Middle East Artificial Intelligence in Diagnostics Market Size and Forecast, By Diagnosis Type
12.4 Middle East Artificial Intelligence in Diagnostics Market Size and Forecast, By Country
13Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
15.1 GE Healthcare
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Siemens Healthcare GmbH
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 IDx Technologies Inc
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Vuno Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Imagen Technologies
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 AliveCor
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Aidoc
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Neural Analytics
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Riverain Technologies
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Zebra Medical Vision
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
